{"id":167,"date":"2025-08-24T07:13:06","date_gmt":"2025-08-24T07:13:06","guid":{"rendered":"https:\/\/myinformernews.com\/usa\/?p=167"},"modified":"2025-08-24T07:13:08","modified_gmt":"2025-08-24T07:13:08","slug":"caredx-settlement","status":"publish","type":"post","link":"https:\/\/myinformernews.com\/usa\/caredx-settlement\/","title":{"rendered":"CareDx Settlement Explained: Eligibility, Claim Deadline, and Payout Details"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">The <strong>CareDx settlement<\/strong> provides eligible investors with an opportunity to recover losses from securities purchased during the class period. <a href=\"https:\/\/caredx.com\/\" target=\"_blank\" rel=\"noopener\">CareDx, Inc.<\/a> agreed to pay $20.25 million to resolve allegations that it misled investors by making false statements about its kidney transplant testing business while engaging in improper billing practices.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">This guide explains who qualifies, how much you can claim, and the steps to submit your settlement form before the deadline.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Who Is Eligible for the CareDx Settlement?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">You may qualify if you purchased <strong>CareDx Inc. common stock<\/strong> between <strong>May 1, 2020, and November 3, 2022<\/strong>, and suffered damages. Eligibility extends to:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Individual investors and institutional investors<\/li>\n\n\n\n<li>Joint owners, estates, trusts, and other legal entities<\/li>\n\n\n\n<li>Executors, administrators, guardians, and trustees (with proof of authority)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">You do not need to sell your securities to be eligible.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How Much Can You Receive?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The settlement fund totals <strong>$20.25 million<\/strong>. The amount each class member receives depends on:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The number of valid claims submitted<\/li>\n\n\n\n<li>The number of shares purchased and sold<\/li>\n\n\n\n<li>The timing of transactions<\/li>\n\n\n\n<li>The total recognized losses of all claimants<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Estimated Recovery<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Average payout before deductions<\/strong>: $0.32 per damaged share<\/li>\n\n\n\n<li><strong>Average payout after deductions<\/strong>: $0.10 per damaged share<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">If your calculated award is <strong>less than $10<\/strong>, you will not receive a payment.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">How Is the Award Calculated?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The recognized loss formula is based on when shares were sold or held:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Sold before October 29, 2021<\/strong> \u2192 Loss = $0<\/li>\n\n\n\n<li><strong>Sold between October 29, 2021, and November 3, 2022<\/strong> \u2192 Loss equals the lesser of:\n<ul class=\"wp-block-list\">\n<li>Difference in artificial inflation per share (per Table A in notice)<\/li>\n\n\n\n<li>Purchase price minus sale price<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Sold between November 4, 2022, and February 1, 2023<\/strong> \u2192 Loss equals the lesser of:\n<ul class=\"wp-block-list\">\n<li>Artificial inflation at purchase date<\/li>\n\n\n\n<li>Purchase price minus average closing price (per Table B)<\/li>\n\n\n\n<li>Purchase price minus sale price<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Held shares as of February 1, 2023<\/strong> \u2192 Loss equals the lesser of:\n<ul class=\"wp-block-list\">\n<li>Artificial inflation on purchase date<\/li>\n\n\n\n<li>Purchase price minus $13.21<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\">How to File a Claim<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">You can file online or by mailing a completed PDF claim form. Each account requires a separate claim form.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Claim deadline:<\/strong> <strong>November 12, 2025<\/strong><br><strong>Mailing address:<\/strong><br>CareDx Securities Litigation<br>c\/o A.B. Data Ltd.<br>P.O. Box 173096<br>Milwaukee, WI 53217<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Documentation Required<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Last four digits of Social Security or Taxpayer ID<\/li>\n\n\n\n<li>Account number and type<\/li>\n\n\n\n<li>Proof of transactions (brokerage statements, trade confirmations, or official broker records)<\/li>\n\n\n\n<li>Proof of authority for executors or representatives<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\">Important Dates<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Exclusion deadline:<\/strong> October 14, 2025<\/li>\n\n\n\n<li><strong>Claim deadline:<\/strong> November 12, 2025<\/li>\n\n\n\n<li><strong>Fairness hearing:<\/strong> December 2, 2025<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Settlement payments will be distributed once the court grants final approval and any appeals are resolved.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Why Is CareDx Paying This Settlement?<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The lawsuit alleged that <strong>CareDx Inc. and its executives misrepresented compliance with federal securities laws and revenue disclosures<\/strong>, which artificially inflated stock prices. While CareDx denies wrongdoing, the company agreed to the settlement to avoid further litigation costs and risk<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>CareDx settlement<\/strong> offers investors who purchased stock during the class period a chance to recover part of their losses. To maximize your eligibility, submit your claim before the November 12, 2025 deadline.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">CareDx Settlement FAQ<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>1. What is the CareDx settlement amount?<\/strong><br>The settlement is valued at <strong>$20.25 million<\/strong>, subject to court approval and deductions for fees and expenses.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>2. Who qualifies for the CareDx settlement?<\/strong><br>Anyone who purchased CareDx common stock between <strong>May 1, 2020, and November 3, 2022<\/strong>, and suffered damages.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>3. How much will investors receive per share?<\/strong><br>The estimated recovery is <strong>$0.32 per damaged share before fees<\/strong> and approximately <strong>$0.10 per share after deductions<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>4. What documents are needed to file a CareDx claim?<\/strong><br>You must provide brokerage account statements, trade confirmations, or official broker records covering transactions during the class period.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>5. What is the CareDx settlement claim deadline?<\/strong><br>Claims must be filed by <strong>November 12, 2025<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>6. When will CareDx settlement payments be distributed?<\/strong><br>Payments are expected within <strong>4 to 9 months after the claim deadline<\/strong>, depending on court approval and appeals.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>7. Do I need to sell my CareDx shares to qualify?<\/strong><br>No. You are eligible whether you held or sold your shares, provided they were purchased during the class period.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The CareDx settlement provides eligible investors with an opportunity to recover losses from securities purchased during the class period. CareDx, Inc. agreed to pay $20.25 million to resolve allegations that it misled investors by making false statements about its kidney transplant testing business while engaging in improper billing practices. This guide explains who qualifies, how [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":168,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"iawp_total_views":170,"footnotes":""},"categories":[5],"tags":[8],"class_list":["post-167","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-class-action-settlements","tag-settlement"],"_links":{"self":[{"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/posts\/167","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/comments?post=167"}],"version-history":[{"count":1,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/posts\/167\/revisions"}],"predecessor-version":[{"id":169,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/posts\/167\/revisions\/169"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/media\/168"}],"wp:attachment":[{"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/media?parent=167"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/categories?post=167"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myinformernews.com\/usa\/wp-json\/wp\/v2\/tags?post=167"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}